KRPIA calls for reappraisal of medical insurance drug prices

The Korean Research-based Pharmaceutical Industry Association (KRPIA) has recently demanded the reappraisal of medical insurance drug prices through the previous review, according to its statement submitted to the Ministry of Health and Welfare. The KRPIA further notes in its statement:

- As for the provision relating to the calculation criteria of medical insurance drug price, the fact that...